Calamos Advisors LLC Organogenesis Holdings Inc. Transaction History

Calamos Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$9.02 - $13.5 $1.97 Million - $2.96 Million	-218,895 Closed	0 $0
Q3 2021 Oct 26, 2021	BUY	$13.71 - $17.18 $445,684 - $558,487	32,508 Added 17.44%	218,895 $3.12 Million
Q2 2021 Jul 22, 2021	BUY	$14.92 - $23.23 $1.82 Million - $2.84 Million	122,292 Added 190.8%	186,387 $3.1 Million
Q1 2021 Apr 12, 2021	BUY	$7.33 - $21.06 $469,816 - $1.35 Million	64,095 New	64,095 $1.17 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.